Fatal TAFRO syndrome in which adrenal hemorrhage preceded thrombocytopenia
- 1Department of Hematology, Shinko Hospital, Kobe, Japan, Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan, Department of Diagnostic Pathology, Shinko Hospital, Kobe, Japan
Abstract
TAFRO syndrome is a rare systemic inflammatory disease characterized by thrombocytopenia, anasarca, fever, renal dysfunction, and myelofibrosis, and its follows a rapidly fatal clinical course. A few cases of TAFRO syndrome complicated by adrenal hemorrhage were recently reported; however, its pathogenetic significance remains largely unclear.
The present case was a 59-year-old man presenting with left lower back pain. Imaging studies revealed left adrenal hemorrhage. Although an elevated C-reactive protein level was observed in the initial visit, there were no obvious abnormalities in the platelet count, renal function, or coagulation profile. Subsequently, fluid retention and renal dysfunction progressed rapidly, and thrombocytopenia emerged, leading to a diagnosis of TAFRO syndrome. Treatment including glucocorticoid therapy was initiated, but was ineffective; the disease progressed rapidly, and the patient succumbed to multiple organ failure. Autopsy revealed findings consistent with TAFRO syndrome in small lymph nodes and those suggestive of thrombotic microangiopathy in renal glomeruli.
Based on these findings, adrenal hemorrhage may occur as an initial presentation prior to the manifestation of the full systemic picture of TAFRO syndrome. Furthermore, the disease progressed rapidly to a severe state in a short period without initial thrombocytopenia—which complicated the diagnosis—and demonstrated resistance to conventional treatments including glucocorticoids, which underscores the importance of early recognition and therapeutic intervention.
Related
- A rare presentation of probable catastrophic antiphospholipid syndrome with bilateral adrenal hemorrhage
- Do Early Prognostic Measures Differentiate Mechanisms of ICU Death in Aneurysmal Subarachnoid Hemorrhage? An Analysis of Fatal Outcomes
- 2D anomaly detection of fatal cerebral hemorrhage on postmortem CT
- Case Report: Presumptive subdural hemorrhage as a rare neurological manifestation of primary immune-mediated thrombocytopenia in a dog.
- Fatal methanol poisoning with paroxysmal sympathetic hyperactivity, and putaminal hemorrhage: a case report and brief literature review
BibTeX
@article{miyazaki2026fatal,
title = {{Fatal TAFRO syndrome in which adrenal hemorrhage preceded thrombocytopenia}},
author = {Madoka Miyazaki and Hiroko Tsunemine and Chika Fujita and Chiho Ohbayashi and Shusaku Take and Yasuhiro Tanaka and Tomoo Itoh and Nobuyoshi Arima},
journal = {Journal of Clinical and Experimental Hematopathology : JCEH},
year = {2026},
month = sep,
doi = {10.3960/jslrt.26031},
url = {https://doi.org/10.3960/jslrt.26031},
note = {CC BY-NC-SA 4.0},
}
RIS
TY - JOUR
TI - Fatal TAFRO syndrome in which adrenal hemorrhage preceded thrombocytopenia
AU - Madoka Miyazaki
AU - Hiroko Tsunemine
AU - Chika Fujita
AU - Chiho Ohbayashi
AU - Shusaku Take
AU - Yasuhiro Tanaka
AU - Tomoo Itoh
AU - Nobuyoshi Arima
PY - 2026
DA - 2026/09/30
JO - Journal of Clinical and Experimental Hematopathology : JCEH
DO - 10.3960/jslrt.26031
UR - https://doi.org/10.3960/jslrt.26031
AB - TAFRO syndrome is a rare systemic inflammatory disease characterized by thrombocytopenia, anasarca, fever, renal dysfunction, and myelofibrosis, and its follows a rapidly fatal clinical course. A few cases of TAFRO syndrome complicated by adrenal hemorrhage were recently reported; however, its pathogenetic significance remains largely unclear. The present case was a 59-year-old man presenting with left lower back pain. Imaging studies revealed left adrenal hemorrhage. Although an elevated C-reactive protein level was observed in the initial visit, there were no obvious abnormalities in the platelet count, renal function, or coagulation profile. Subsequently, fluid retention and renal dysfunction progressed rapidly, and thrombocytopenia emerged, leading to a diagnosis of TAFRO syndrome. Treatment including glucocorticoid therapy was initiated, but was ineffective; the disease progressed rapidly, and the patient succumbed to multiple organ failure. Autopsy revealed findings consistent with TAFRO syndrome in small lymph nodes and those suggestive of thrombotic microangiopathy in renal glomeruli. Based on these findings, adrenal hemorrhage may occur as an initial presentation prior to the manifestation of the full systemic picture of TAFRO syndrome. Furthermore, the disease progressed rapidly to a severe state in a short period without initial thrombocytopenia—which complicated the diagnosis—and demonstrated resistance to conventional treatments including glucocorticoids, which underscores the importance of early recognition and therapeutic intervention.
SN - 1346-4280
SN - 1880-9952
ER -